Correspondingly, recent clinical data showed that patients with NAFLD had significantly compromised cardiac and autonomic function, and, in particular, the raised levels of TNF-α and CK-18 (as markers for liver injury) in NAFLD patients were independently connected with augmented sympathetic activity and reduced parasympathetic activity [179]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.